IMUC: Immunotherapy On Multiple Fronts
In a study of 19 patients with glioblastoma, progression-free survival increased from 6 months to 19 months.
News
NeoMatrix: A “Pap Smear for Breast Cancer”
Neomatrix of Irvine, Calif., has developed a fully automated, non-invasive device to assess a patient’s risk of developing breast cancer.
Quantum Immunologics’ Alternative to Chemotherapy
The company’s vaccine technology is based on the universal tumor antigen, which has been expressed in all human cancers studied so far.
MicroTransponder Receives $9.6M Funding for Wireless Pain Treatment
MicroTransponder is developing a wireless neurostimulation device for the treatment of chronic pain.
An Amplifier for Diagnostic Tests
Sword Diagnostics of Illinois has developed a “next-generation” system to increase the sensitivity (and therefore accuracy) of diagnostic tests.
Viveve Highlights Widespread Post-Childbirth Issue
There’s one change that women don’t always discuss with their gynecologists.
Jaleva Pharmaceuticals: Drug Delivery for Dermatology Treatments
Jaleva’s Stayzon technology utilizes a specific formulation of resins that is designed to keep medication in place for up to 96 hours and provide extended-release drug delivery to the skin.
LAMP May Light the Way to New Generation of Vaccines
LAMP (Lysosome-Associated Membrane Protein) is a gene that has been shown to enhance immune response when incorporated into a DNA vaccine.
SEA Medical: Technology to Prevent Deadly IV Mistakes
Intravenous (IV) drugs leave a huge margin for human error, particularly at the point of administration.
Defining a Radiation Target with Augmenix
The company’s SpaceOAR System is designed to temporarily separate organs during radiotherapy so that normal tissues are spared, and to mark tumor resection sites to allow for targeted therapy.